Skip to Content
Author: The BCW

Leave a Comment

Regeneron Gets FDA Approval for EYLEA’s Pediatric Treatment

In another breakthrough for BCW Member Regeneron Pharmaceuticals, the U.S. Food and Drug Administration (FDA) has approved the company’s EYLEA® (aflibercept) Injection to treat preterm infants with retinopathy of prematurity (ROP). Following this first pediatric approval, EYLEA is now indicated to treat five retinal conditions caused by ocular angiogenesis.

“Retinopathy of prematurity is a leading cause of childhood blindness worldwide. Until now, the only FDA-approved treatment in common use was laser photocoagulation, a complex and lengthy procedure that permanently ablates retina tissue and is stressful not only for infant patients but also the family navigating a delicate time after a preterm birth,” said George D. Yancopoulos, M.D., Ph.D., President and Chief Scientific Officer of Regeneron, and a principal inventor of EYLEA. “For the first time, physicians will now have an FDA approved medication in EYLEA to treat this heartbreaking disease in these smallest of patients. We thank the investigators and the many families who participated in the clinical trials.”

Each year in the U.S., between 1,100 to 1,500 infants develop ROP that is severe enough to require medical treatment. This rare eye disease often impacts infants who are born before 31 weeks of pregnancy have been completed or who weigh less than 3.3 lbs pounds at birth. “Regeneron’s trials investigating EYLEA in retinopathy of prematurity have advanced our understanding of how to treat this disease and provided a needed evidence-based treatment option to potentially help preterm infants preserve their vision,” said Jeff Todd, Chief Executive Officer of Prevent Blindness.

EYLEA is being jointly developed by Regeneron and Bayer.

Similar News Items

BCW Member Maria Fareri Children’s Hospital appears on U.S. News & World Report’s 2025–2026 Best Children’s Hospitals list, earning a coveted spot in the 2025–2026 Best Children’s Hospitals for Pediatric Cancer. In addition to this national recognition, Maria Fareri Children’s Hospital was named the #7 Best Children’s Hospital in New York and the #16 Best in the […]

Read Article

Westchester County is investing nearly $10 million in the development of 160 new affordable rental units in Yonkers, with County Executive Ken Jenkins signing legislation to move the project forward. The legislation, enacted in partnership with the Westchester County Board of Legislators, the City of Yonkers, and BCW member MacQuesten Development, LLC, is aimed at […]

Read Article

The Business Council of Westchester and our coalition, A Sure Bet for New York’s Future, are deeply disappointed by Wednesday’s announcement that MGM Empire City will withdraw from the casino licensing process. Throughout the many years of this effort, we have fought tirelessly with the MGM Empire City team to ensure that this important local […]

Read Article

Become A Member

Join the county’s largest and most influential business organization today.

JOIN NOW!
The Business Council of Westchester is committed to helping businesses market, learn, advocate, and grow. Over 80 events and programs are offered every year, giving our members ample opportunity to connect and meet with businesses representatives in the Westchester community and beyond.
Back to top